Drug application

GLYBURIDE (GLYBURIDE)

Drugs@FDA ANDA 203581 · CHARTWELL RX

Key facts

Drug name GLYBURIDE
Active ingredients GLYBURIDE
Application type ANDA
Application number 203581
Company CHARTWELL RX
Dosage forms TABLET, ORAL
Strength 1.25MG
Marketing status Discontinued
Reference listed drug No
Latest submission status date Apr 14, 2016

At a glance

  • 1–9 Submissions
  • None Label versions
  • 1–9 Products
  • None Therapeutic equivalents

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Drugs@FDA applications

Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.

Source: U.S. Food and Drug Administration (FDA), Drugs@FDA

Browse all Drugs@FDA applications